Great post SanFran.

While you and I disagree re Don you make good points...e.g Dr Cherrington.

However, for all of the good Don has done he is at his "Peter Principle" level. The reason I say this now is because of his commitments in Feb and the Richmond Club hyperbole.

I do feel strongly that clear and effective communication is needed and it needs to be regular. I still think rvx-208 is a winner but it needs to be presented in a realistic context. For example, they could let us know clearly what is being done with the FDA. They could be clear about their EU approval...their statement seemed to be evasive. This creates uncertainty and for a person like me who was very convinced of the science it has raised doubts.

So if the science really has "legs" then they should be communicating effectively. I believe that the very poor communications has been a drag on the share price. Poor communications by RVX has created large doubts among potential investors.

I also do not believe they read these blogs and if they do they do not care. Sarah said as much. Otherwise, we would see a very different situation at RVX. They have the money. The share price is irrelevant for Don. They will carry on in Europe and China and they will continue to work with the FDA.

There are many positive signals such as Hepalink and all of the other factors we know but Don is a clear drag.

Even with all of the great progress to date I am currently disappointed, particularly because Don has eroded confidence AND this will not change because he does not get it nor does he care. He has been steady at the tiller, and at $500,000 per year he will sit back and relax until whatever trials get completed in the next 3 years.

So GLTA and DYODD.

Cheers

Toinv